vs

Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

Cipher Mining Inc. is the larger business by last-quarter revenue ($59.7M vs $57.3M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -83.0% vs -1229.6%, a 1146.6% gap on every dollar of revenue. On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs 36.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 11.4%).

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

CIFR vs RYTM — Head-to-Head

Bigger by revenue
CIFR
CIFR
1.0× larger
CIFR
$59.7M
$57.3M
RYTM
Growing faster (revenue YoY)
CIFR
CIFR
+4.5% gap
CIFR
41.4%
36.9%
RYTM
Higher net margin
RYTM
RYTM
1146.6% more per $
RYTM
-83.0%
-1229.6%
CIFR
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
11.4%
CIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIFR
CIFR
RYTM
RYTM
Revenue
$59.7M
$57.3M
Net Profit
$-734.2M
$-47.5M
Gross Margin
59.4%
91.6%
Operating Margin
-503.4%
-82.2%
Net Margin
-1229.6%
-83.0%
Revenue YoY
41.4%
36.9%
Net Profit YoY
-4293.1%
-9.6%
EPS (diluted)
$-1.91
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIFR
CIFR
RYTM
RYTM
Q4 25
$59.7M
$57.3M
Q3 25
$71.7M
$51.3M
Q2 25
$43.6M
$48.5M
Q1 25
$49.0M
$32.7M
Q4 24
$42.2M
$41.8M
Q3 24
$24.1M
$33.3M
Q2 24
$36.8M
$29.1M
Q1 24
$48.1M
$26.0M
Net Profit
CIFR
CIFR
RYTM
RYTM
Q4 25
$-734.2M
$-47.5M
Q3 25
$-3.3M
$-52.9M
Q2 25
$-45.8M
$-46.6M
Q1 25
$-39.0M
$-49.5M
Q4 24
$17.5M
$-43.3M
Q3 24
$-86.8M
$-43.6M
Q2 24
$-15.3M
$-32.3M
Q1 24
$39.9M
$-141.4M
Gross Margin
CIFR
CIFR
RYTM
RYTM
Q4 25
59.4%
91.6%
Q3 25
62.7%
89.3%
Q2 25
64.8%
88.6%
Q1 25
69.6%
88.8%
Q4 24
56.9%
90.9%
Q3 24
37.5%
88.5%
Q2 24
61.2%
89.9%
Q1 24
69.2%
89.2%
Operating Margin
CIFR
CIFR
RYTM
RYTM
Q4 25
-503.4%
-82.2%
Q3 25
-52.5%
-102.6%
Q2 25
-103.9%
-93.4%
Q1 25
-77.8%
-143.7%
Q4 24
40.5%
-98.6%
Q3 24
-379.2%
-132.0%
Q2 24
-43.9%
-139.2%
Q1 24
97.2%
-538.7%
Net Margin
CIFR
CIFR
RYTM
RYTM
Q4 25
-1229.6%
-83.0%
Q3 25
-4.6%
-103.1%
Q2 25
-105.1%
-96.1%
Q1 25
-79.6%
-151.4%
Q4 24
41.5%
-103.6%
Q3 24
-359.9%
-131.2%
Q2 24
-41.5%
-110.9%
Q1 24
82.9%
-544.4%
EPS (diluted)
CIFR
CIFR
RYTM
RYTM
Q4 25
$-1.91
$-0.73
Q3 25
$-0.01
$-0.82
Q2 25
$-0.12
$-0.75
Q1 25
$-0.11
$-0.81
Q4 24
$0.04
$-0.71
Q3 24
$-0.26
$-0.73
Q2 24
$-0.05
$-0.55
Q1 24
$0.13
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIFR
CIFR
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$628.3M
$388.9M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$805.5M
$139.1M
Total Assets
$4.3B
$480.2M
Debt / EquityLower = less leverage
3.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIFR
CIFR
RYTM
RYTM
Q4 25
$628.3M
$388.9M
Q3 25
$1.2B
$416.1M
Q2 25
$62.7M
$291.0M
Q1 25
$23.2M
$314.5M
Q4 24
$5.6M
$320.6M
Q3 24
$25.3M
$298.4M
Q2 24
$122.6M
$319.1M
Q1 24
$88.7M
$201.2M
Total Debt
CIFR
CIFR
RYTM
RYTM
Q4 25
$2.7B
Q3 25
$1.0B
Q2 25
$167.1M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CIFR
CIFR
RYTM
RYTM
Q4 25
$805.5M
$139.1M
Q3 25
$783.2M
$148.8M
Q2 25
$748.9M
$-11.9M
Q1 25
$734.8M
$18.9M
Q4 24
$682.0M
$21.7M
Q3 24
$672.0M
$11.2M
Q2 24
$690.8M
$39.3M
Q1 24
$600.9M
$61.6M
Total Assets
CIFR
CIFR
RYTM
RYTM
Q4 25
$4.3B
$480.2M
Q3 25
$2.8B
$506.9M
Q2 25
$1.0B
$372.7M
Q1 25
$913.8M
$386.7M
Q4 24
$855.4M
$392.3M
Q3 24
$775.4M
$363.6M
Q2 24
$775.6M
$381.8M
Q1 24
$677.1M
$258.7M
Debt / Equity
CIFR
CIFR
RYTM
RYTM
Q4 25
3.37×
Q3 25
1.31×
Q2 25
0.22×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIFR
CIFR
RYTM
RYTM
Operating Cash FlowLast quarter
$-207.9M
$-25.4M
Free Cash FlowOCF − Capex
$-695.9M
FCF MarginFCF / Revenue
-1165.4%
Capex IntensityCapex / Revenue
817.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIFR
CIFR
RYTM
RYTM
Q4 25
$-207.9M
$-25.4M
Q3 25
$-50.1M
$-26.6M
Q2 25
$-56.2M
$-23.3M
Q1 25
$-47.2M
$-40.4M
Q4 24
$-87.5M
$-18.8M
Q3 24
$-6.5M
$-25.2M
Q2 24
$-25.4M
$-29.1M
Q1 24
$-26.6M
$-40.7M
Free Cash Flow
CIFR
CIFR
RYTM
RYTM
Q4 25
$-695.9M
Q3 25
$-256.2M
Q2 25
$-87.5M
Q1 25
$-71.8M
Q4 24
$-227.0M
Q3 24
$-83.2M
Q2 24
$-33.2M
Q1 24
$-34.5M
FCF Margin
CIFR
CIFR
RYTM
RYTM
Q4 25
-1165.4%
Q3 25
-357.3%
Q2 25
-200.9%
Q1 25
-146.7%
Q4 24
-537.6%
Q3 24
-345.0%
Q2 24
-90.2%
Q1 24
-71.7%
Capex Intensity
CIFR
CIFR
RYTM
RYTM
Q4 25
817.1%
Q3 25
287.5%
Q2 25
71.8%
Q1 25
50.2%
Q4 24
330.4%
Q3 24
317.8%
Q2 24
21.4%
Q1 24
16.4%
Cash Conversion
CIFR
CIFR
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-5.00×
Q3 24
Q2 24
Q1 24
-0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons